Evidence map›Paper›PMID 39281937›Full record

ArticleACS omega2024

Ceramide 3 Effect on the Physical Properties of Ambora Extract and Chromabright-Loaded Transethosomes.

Derya Karagöz Girişgen, Naz Zeynep Atay, Özge Ceren Yalçin, Elif Mey Öztürk

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Derya Karagöz GirişgenDepartment of Chemistry, Institute for Graduate Science and Engineering, Boğaziçi University, Istanbul 34342, Turkey.
Naz Zeynep AtayDepartment of Chemistry, Faculty of Arts and Sciences, Boğaziçi University, Istanbul 34342, Turkey.ORCID https://orcid.org/0000-0002-7148-7827
Özge Ceren YalçinDepartment of Chemistry, Faculty of Arts and Sciences, Boğaziçi University, Istanbul 34342, Turkey.
Elif Mey ÖztürkDepartment of Chemistry, Faculty of Arts and Sciences, Boğaziçi University, Istanbul 34342, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spontaneous self-assembly of phospholipids into lipid vesicles in aqueous media is called liposomes, and these structures are widely used as nanocarriers in the cosmeceutical industry. Transethosomes are ethanol and edge activator-containing liposomes that are proven to be very effective in topical applications for penetrating the skin barrier. Many cosmeceutical products contain formulations with ceramides to restore the skin barrier and treat eczema. However, due to the low solubility and penetration ability of the ceramides, the effectiveness of these products is limited. In this study, a transethosome formulation containing ceramide 3 (Cer 3) was achieved by introducing varying concentrations of cholesterol and an edge activator (Tween 80) to improve the effect of the skin products used to treat eczema. The obtained transethosomes were examined in terms of size, homogeneity, zeta potential, morphology, and one-month stability. Loading capability experiments were carried out with lipophilic Chromabright and hydrophilic Ambora extract. The effect of Cer 3 on the loading of the selected payloads was evaluated. Data were analyzed statistically with linear regression analysis and two-way analysis of variance. The results showed that the inclusion of Cer 3 had almost no effect on the physical properties of the loaded or empty transethosomes. Independently of the presence of Cer 3, loading of the lipophilic compound was more efficient than that of the hydrophilic one.

Identifiers

PMID39281937
PMCPMC11391439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.